2017 HomeCare Elite Recognizes Top Amedisys Care Centers Nationwide
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys (AMED) PT Raised to $60 at Baird Following 3Q
November 10, 2017 8:56 AM ESTBaird raised its price target on Amedisys (NASDAQ: AMED) to $60.00 (from $50.00) while maintaining a Neutral rating following the company's 3Q release. 3Q17 revenues of $386.7m beat consensus of $385.3m by 0.4%. EBITDA of $36.9m beat consensus of $35.5m by 3.9% and EPS of $0.56 exceeded consensus at $0.53... More



